Effects of modafinil on dopamine and dopamine transporters in the male human brain clinical implications

JAMA

Volumn 301, Issue 11, 2009, Pages 1148-1154

  Volkow, Nora D ^a,b   Fowler, Joanna S ^c,d,e   Logan, Jean ^c   Alexoff, David ^c   Zhu, Wei ^f   Telang, Frank ^a   Wang, Gene Jack ^c,d   Jayne, Millard ^a   Hooker, Jacob M ^c   Wong, Christopher ^c   Hubbard, Barbara ^c   Carter, Pauline ^c   Warner, Donald ^c   King, Payton ^c   Shea, Colleen ^c   Xu, Youwen ^c   Muench, Lisa ^a   Apelskog Torres, Karen ^c  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c BROOKHAVEN NATIONAL LABORATORY   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e STONY BROOK UNIVERSITY   (United States)

^f Stony Brook University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE TRANSPORTER; METHYLPHENIDATE; MODAFINIL; PLACEBO; RACLOPRIDE C 11; RADIOLIGAND; BENZHYDRYL DERIVATIVE; CARBON; CENTRAL STIMULANT AGENT; DIAGNOSTIC AGENT; RACLOPRIDE;

ADDICTION; ADULT; ARTICLE; BRAIN; CAUDATE NUCLEUS; COGNITION; DOPAMINERGIC SYSTEM; DRUG BINDING; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMAGING SYSTEM; MALE; NARCOLEPSY; NEUROPHARMACOLOGY; NORMAL HUMAN; NUCLEUS ACCUMBENS; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROFILE OF MOOD STATES; PUTAMEN; RECEPTOR OCCUPANCY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MIDDLE AGED; SCINTISCANNING;

ADULT; BENZHYDRYL COMPOUNDS; BRAIN; CARBON RADIOISOTOPES; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MALE; MIDDLE AGED; NUCLEUS ACCUMBENS; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; PUTAMEN; RACLOPRIDE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 62649136134     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.351     Document Type: Article

References (38)

1. Minzenberg MJ, Carter CS. Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology. 2008;33(7):1477-1502.
2. Enhancing, not cheating. Nature. 2007;450(7168):320.
3. Provigil (modafinil). In: 2006 Physicians' Desk Reference. 60th ed. Montvale, NJ: Thompson PDR;2006:1002-1007.
4. KruszewskiSP, KlotzSG. Modafinil: mischaracterization. J Clin Psychiatry. 2007;68(6):970-971.
5. Kruszewski SP. Euphorigenic and abusive properties of modafinil. Am J Psychiatry. 2006;163(3):549.
6. Greenhill LL. The science of stimulant abuse. Pediatr Ann. 2006;35(8):552-556.
7. Lin JS, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-and modafinil-induced wakefulness, evidenced bycfos immunocytochemistry in the cat. Proc Natl Acad Sci USA. 1996;93(24):14128-14133.
8. Scammell TE, Estabrooke IV, McCarthy MT, et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci. 2000;20(22):8620-8628.
9. WisorJP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM. Dopaminergic role in stimulant-induced wakefulness. J Neurosci. 2001;21(5):1787-1794.
10. Ferraro L, Antonelli T, O'Connor WT, Tanganelli S, Rambert FA, Fuxe K. Modafinil: an antinarcoleptic drug with a different neurochemical profile to d- amphetamine and dopamine uptake blockers. Biol Psychiatry. 1997;42(12):1181-1183.
11. de Saint Hilaire Z, Orosco M, Rouch C, Blanc G, Nicolaidis S. Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats. Neuroreport. 2001;12(16):3533-3537.
12. Murillo-Rodriguez E, Haro R, Palomero-Rivero M, Millan-Aldaco D, Drucker-Colin R. Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats. Behav Brain Res. 2007;176(2):353-357.
13. Madras BK, Xie Z, Lin Z, et al. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther. 2006;319 (2):561-569.
14. Minzenberg MJ, Watrous AJ, Yoon JH, Ursu S, Carter CS. Modafinil shifts human locus coeruleus to low tonic, high-phasic activity during functional MRI. Science. 2008;322(5908):1700-1702.
15. Volkow N, Li TK. The neuroscience of addiction. Nat Neurosci. 2005;8(11):1429-1430.
16. Biederman J, Swanson JM, Wigal SB, Boellner SW, Earl CQ, Lopez FA; Modafinil ADHD Study Group. A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study. J Clin Psychiatry. 2006;67(5):727-735.
17. 11C]raclopride in the human brain. Synapse. 1994;16(4):255-262.
18. Fowler JS, Volkow ND, Wolf AP, et al. Mapping cocaine binding sites in human and baboon brain in vivo. Synapse. 1989;4(4):371-377.
19. Ehrin E, Gawell L, Hogberg T, Depaulis T, Strom P. Synthesis of [methoxy-3H]-and [methoxy-11C]- labelled raclopride: specific dopamine-D2 receptor ligands. J Labelled Comp Radiopharm. 1987;24 (8):931-940.
20. Alexoff DL, Shea C, Fowler JS, et al. Plasma input function determination for PET using a commercial laboratory robot. Nucl Med Biol. 1995;22(7):893-904.
21. Wang GJ, Volkow ND, Hitzemann RJ, et al. Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers. Eur Addict Res. 1997;3:49-54.
22. MacNair DM, Lorr M, Droppelman LF. EDITS Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service; 1971.
23. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10(5):740-747.
24. 11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab. 1994;14(6):995-1010.
25. SPM: Statistical Parametric Mapping. http://www.fil.ion.ucl.ac.uk/spm/. Accessed February 18, 2009.
26. Volkow ND, Wang GJ, Fowler JS, et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry. 1998;155(10):1325-1331.
27. Volkow ND, Wang GJ, Fowler JS, et al. "Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse. 2002;44(3):175-180.
28. SAS/STAT 9.2 user's guide. SAS Institute Inc. http://support.sas.com/ documentation/onlinedoc/stat /index.html. Accessed February 18, 2009.
29. Crone C. The permeability of capillaries in various organs as determined by the use of the "indicator diffusion" method. Acta Physiol Scand. 1963;58:292-305.
30. Joo EY, Tae WS, Jung KY, Hong SB. Cerebral blood flow changes in man bywake-promoting drug, modafinil: a randomized double blind study. J Sleep Res. 2008;17(1):82-88.
31. Volkow ND, Wang GJ, Fowler JS, et al. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse. 2002;43(3):181-187.
32. Myrick H, Malcolm R, Taylor B, LaRowe S. Modafinil: preclinical, clinical and post-marketing surveillance: a review of abuse liability issues. Ann Clin Psychiatry. 2004;16(2):101-109.
33. Gold LH, Balster RL. Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology(Berl). 1996;126(4):286-292.
34. Stoops WW, Lile JA, Fillmore MT, Glaser PEA, Rush CR. Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology (Berl). 2005;182(1):186-193.
35. Jasinski DR, Kovacevic-Ristanovic R. Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy. Clin Neuropharmacol. 2000;23(3):149-156.
36. Hart CL, Haney M, Vosburg SK, Rubin E, Foltin RW. Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology. 2008;33(4):761-768.
37. Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP. Adouble-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology. 2005;30(1):205-211.
38. Gjedde A, Wong DF, Rosa-Neto P, Cumming P. Mapping neuroreceptors atwork: on the definition and interpretation of binding potentials after 20 years of progress. Int Rev Neurobiol. 2005;63:1-20.